Loading
Search
▼ Japan To Locally Produce Astrazeneca Vaccine
- Category:Other
Total of 378,274 coronavirus cases, including over 5,400 deaths, reported in Japan
Japan on Thursday confirmed it will locally produce a COVID-19 vaccine manufactured by Britain’s pharmaceutical giant AstraZeneca .
Speaking at a news conference in the capital Tokyo, Japan’s Chief Cabinet Secretary Katsunobu Kato said: “Yesterday, we received a report […] from AstraZeneca, informing us that it will aim to manufacture over 90 million doses within Japan.”
Japan had signed a deal with AstraZeneca to acquire 120 million doses of the vaccine.
According to Kyodo news agency, 75% of all AstraZeneca vaccines will be manufactured in Japan.
Japanese JCR Pharmaceuticals based in western Hyogo province is expected to be the partner of AstraZeneca.
Japan has reported a total of 378,274 coronavirus cases, including over 5,400 deaths.
US drugmaker Pfizer has also applied for the approval of its vaccine in Japan.
Japan on Thursday confirmed it will locally produce a COVID-19 vaccine manufactured by Britain’s pharmaceutical giant AstraZeneca .
Speaking at a news conference in the capital Tokyo, Japan’s Chief Cabinet Secretary Katsunobu Kato said: “Yesterday, we received a report […] from AstraZeneca, informing us that it will aim to manufacture over 90 million doses within Japan.”
Japan had signed a deal with AstraZeneca to acquire 120 million doses of the vaccine.
According to Kyodo news agency, 75% of all AstraZeneca vaccines will be manufactured in Japan.
Japanese JCR Pharmaceuticals based in western Hyogo province is expected to be the partner of AstraZeneca.
Japan has reported a total of 378,274 coronavirus cases, including over 5,400 deaths.
US drugmaker Pfizer has also applied for the approval of its vaccine in Japan.
- January 29, 2021
- Comment (0)
- Trackback(0)